Krystal Biotech (NASDAQ:KRYS) Stock Price Up 7.1% After Analyst Upgrade
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) rose 7.1% during trading on Thursday after Citigroup raised their price target on the stock from $206.00 to $215.00. Citigroup currently has a neutral rating on the stock. Krystal Biotech traded as high as $186.69 and last traded at $188.63. Approximately 82,372 shares traded hands […]
More Stories
Watchdog Finds 9 Large US Banks Actively Engaged in Debanking
By Naveen Athrappully Nine of the largest banks have been found to engage in debanking activities, according to preliminary findings...
US Coast Guard Operation Seizes 150,000 Pounds of Cocaine
By Naveen Athrappully More than 150,000 pounds of cocaine have been seized in the Eastern Pacific Ocean since the launch...
Number of Americans Receiving Unemployment Benefits Falls to 10-Month Low
By Andrew Moran The number of Americans collecting unemployment benefits has slipped to its lowest point in 10 months, the...
US Trade Deficit Unexpectedly Falls to 5-Year Low as Exports Surge
By Andrew Moran President Donald Trump’s tariffs helped shrink the U.S. trade deficit to its lowest monthly level in more...
CDC Advisers Turn Focus to Aluminum in Vaccines
By Zachary Stieber A common adjuvant in vaccines is under scrutiny by a panel that has initiated multiple changes to...
7 Best TextNow Alternatives for Free Calling in 2026
Free calling apps like TextNow are being widely used today for smooth global communication without needing extra hardware and software....